LGI4
Leucine-rich repeat LGI family member 4
Also known as: LGI4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N135
- Gene
- LGI4
- Ensembl
- ENSG00000153902
- Chromosome
- 19
- Canonical length
- 537 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted in brain
OverviewNCBI Gene
Involved in regulation of myelination. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Implicated in arthrogryposis multiplex congenita-1 and childhood absence epilepsy. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
537 residues, UniProt reviewed canonical sequence.
>Q8N135|LGI4
1 MGGAGILLLL LAGAGVVVAW RPPKGKCPLR CSCSKDSALC EGSPDLPVSF SPTLLSLSLV
61 RTGVTQLKAG SFLRIPSLHL LLFTSNSFSV IEDDAFAGLS HLQYLFIEDN EIGSISKNAL
121 RGLRSLTHLS LANNHLETLP RFLFRGLDTL THVDLRGNPF QCDCRVLWLL QWMPTVNASV
181 GTGACAGPAS LSHMQLHHLD PKTFKCRAIE LSWFQTVGES ALSVEPFSYQ GEPHIVLAQP
241 FAGRCLILSW DYSLQRFRPE EELPAASVVS CKPLVLGPSL FVLAARLWGG SQLWARPSPG
301 LRLAPTQTLA PRRLLRPNDA ELLWLEGQPC FVVADASKAG STTLLCRDGP GFYPHQSLHA
361 WHRDTDAEAL ELDGRPHLLL ASASQRPVLF HWTGGRFERR TDIPEAEDVY ATRHFQAGGD
421 VFLCLTRYIG DSMVMRWDGS MFRLLQQLPS RGAHVFQPLL IARDQLAILG SDFAFSQVLR
481 LEPDKGLLEP LQELGPPALV APRAFAHITM AGRRFLFAAC FKGPTQIYQH HEIDLSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against LGI4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 102 nTPM
Expression across tissuesHPA
Tissue
- colon: 102 nTPM
- spinal cord: 78 nTPM
- adipose tissue: 77 nTPM
- vagina: 77 nTPM
- cerebral cortex: 76 nTPM
- cervix: 74 nTPM
Single-cell type
- schwann cells: 722 nCPM
- bergmann glia: 305 nCPM
- pericytes: 204 nCPM
- cardiomyocytes: 128 nCPM
- astrocytes: 126 nCPM
- vascular smooth muscle cells: 98 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- medulla oblongata: 94 nTPM
- white matter: 81 nTPM
- cerebral cortex: 66 nTPM
- spinal cord: 65 nTPM
- basal ganglia: 62 nTPM
- thalamus: 61 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LGI4.
Disease | AllUniProt
Conditions LGI4 is implicated in, by any mechanism.
- Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect (AMC1) MIM:617468
Disease | GeneticClinVar
19 pathogenic / likely-pathogenic of 158 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect
- Arthrogryposis multiplex congenita 2, neurogenic type
- Arthrogryposis multiplex congenita
- Fetal akinesia deformation sequence 1
Disease | ImmuneIEDB
Conditions an epitope on LGI4 was assayed in.
- glioblastoma T cell
ReferencesPubMed · IEDB
Publications for LGI4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy.
2023 · Neurol Neuroimmunol Neuroinflamm · RCR 2.3 · 16 citations - Clinical Spectrum, Pathology, and Mechanisms of Anti-LGI4 Antibody-Positive Autoimmune Nodopathy.
2025 · Neurol Neuroimmunol Neuroinflamm · 1 citations
Reference: T cellIEDB
1 publication
- Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma.
2022 · Clin Cancer Res · RCR 0.6 · 10 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.07
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult locomotory behavior
- glial cell proliferation
- myelination in peripheral nervous system
- neuron maturation
- regulation of myelination
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LGI4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LGI4 as an antibody target. Whether an autoantibody or antibody against LGI4 could matter depends on whether native LGI4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LGI4 is annotated as secreted, so native LGI4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LGI4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...